{
    "title": "Gilead targets remdesivir supply for 2 mln COVID-19 patients by year-end",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8448647/Gilead-targets-remdesivir-supply-2-mln-COVID-19-patients-year-end.html",
    "date": "2020-06-22",
    "keywords": [
        "remdesivir",
        "drug",
        "company",
        "monday",
        "virus",
        "use",
        "approval",
        "treatment",
        "inc",
        "year",
        "end",
        "covid19",
        "target",
        "august",
        "easiertouse",
        "version",
        "medicine",
        "forefront",
        "fight",
        "recovery",
        "trial",
        "emergency",
        "authorization",
        "japan",
        "fastspreading",
        "world",
        "worldwide",
        "supply",
        "executive",
        "officer",
        "daniel",
        "oday",
        "statement",
        "june",
        "httpsbitly3eqpej9",
        "cipla",
        "ltd",
        "sunday",
        "country",
        "hetero",
        "milligram",
        "dose",
        "gilead",
        "licensing",
        "price",
        "course",
        "analyst",
        "michael",
        "formulation",
        "nebulizer",
        "wave",
        "infusion",
        "writing",
        "chakrabarty",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}